Intraperitoneal guanosine has been shown to prevent quinolinic acid-induced
seizures in mice. in this study, we investigated the effect of orally admi
nistered guanosine on seizures induced by the glutamate agonists quinolinic
acid and kainate, and the endogenous glutamate releaser alpha -dendrotoxin
. Guanosine (7.5 mg/kg, per os), administered 75 min in advance, prevented
70% of seizures induced by i.c.v. quinolinic acid, being as efficient as th
e NMDA channel blocker MK-801 administered intraperitoneally. Guanosine was
ineffective against kainate-induced seizures, but significantly reversed t
he potentiation of seizures and death caused by the concomitant injection o
f MK-801. Guanosine also significantly prevented seizures and death induced
by i.c.v. alpha -dendrotoxin, whereas MK-801 and phenobarbital only preven
ted death. Altogether, our findings underscore the therapeutic potential of
oral administration of guanosine for treating diseases involving glutamate
rgic excitotoxicity, including epilepsy. (C) 2001 Elsevier Science B.V. All
rights reserved.